Search
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (Vancomycin Hydrochloride for Oral Solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit
… als-inc-issues-voluntary-nationwide-recall-one-lot-firvanqr-vancomycin … Wilmington, MA, Azurity Pharmaceuticals, Inc. … (“Azurity”) is voluntarily recalling one lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit (“Firvanq®”) to the consumer level, …
A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation
… of patients who have received intraocular injections of vancomycin (anti-infective) formulations toward the end of … (steroid), moxifloxacin (anti-infective), and vancomycin formulation. Adverse Event FDA received an adverse … of a compounded triamcinolone, moxifloxacin, and vancomycin (TMV) formulation in each eye at the conclusion of …
Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, Due To The Presence of Visible Glass Particulates
… erts/hospira-inc-issues-voluntary-nationwide-recall-one-lot-vancomycin-hydrochloride-injection-usp … December 22, 2022 - … a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride Injection, USP, 1.5 g/vial Single … reports of any adverse events related to this recall. Vancomycin Hydrochloride is an antibiotic indicated for the …
Leiters Health Issues Voluntary Nationwide Recall of Vancomycin IV Bags, Phenylephrine IV Bags, and Fentanyl IV Bags Due to Potential for Superpotent Drug
… ty-alerts/leiters-health-issues-voluntary-nationwide-recall-vancomycin-iv-bags-phenylephrine-iv-bags-and … FOR IMMEDIATE … listed below to the user level. The recalled batches of vancomycin IV bags, phenylephrine IV bags, and fentanyl IV … 3/19/2024 2331190 3/26/2024 2331429 4/28/2024 F3206 Vancomycin HCl 1.25 g PF added to 0.9% Sodium Chloride 250 mL …
Hospira Issues A Voluntary Nationwide Recall For One Lot Of Vancomycin Hydrochloride for Injection, USP Due To The Presence of Particulate Matter Within a Single Vial
… y-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-vancomycin-hydrochloride-injection-usp-due … Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection, USP (NDC: … every step in the manufacturing and supply chain process. Vancomycin Hydrochloride is indicated for the treatment of …
Hospira Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial Due to The Presence of Particulate Matter Within a Single Vial
… y-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-vancomycin-hydrochloride-injection-usp-750-mgvial … Hospira, … a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial (NDC … every step in the manufacturing and supply chain process. Vancomycin Hydrochloride is indicated for the treatment of …
Vancomycin – Injection products
… /drugs/development-resources/vancomycin-injection-products … Recognized Interpretive … pneumoniae … Center for Drug Evaluation and Research … Vancomycin – Injection products … Vancomycin – Injection products …
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
… neal-pharmaceuticals-llc-issues-nationwide-voluntary-recall-vancomycin-hydrochloride-oral-solution … FOR IMMEDIATE … is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL … the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, …
Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus
… fda-science-forum/characterizing-phage-resistance-mutations-vancomycin-resistant-enterococcus … Office of the … spp. Our group has identified several mutants of Vancomycin resistant Enterococcus that have acquired … strain … Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus …
BAM Media M192a: Modified Buffered Peptone water with pyruvate (mBPWp) and Acriflavin-Cefsulodin-Vancomycin (ACV) Supplement
… ered-peptone-water-pyruvate-mbpwp-and-acriflavin-cefsulodin-vancomycin … July 2009 Bacteriological Analytical Manual … Sterilize by autoclaving. Acriflavin-Cefsulodin-Vancomycin (ACV) Supplement for mBPWp Supplement Conc. in … g/ 500 mL 1 mL Cefsulodin 10mg/L 1.125 g/ 500 mL 1 mL Vancomycin 8mg/L 0.90 g/ 500 mL 1 mL Filter, sterilize. Add …
Immunological and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization
… cal-and-microbial-responses-bacteriophage-therapy-targeting-vancomycin-resistant … Office of the Commissioner … … and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization …
Immunological and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization
… and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus colonization Berkson, … using a mouse model of bacteriophage therapy that targets vancomycin- resistant enterococcus (VRE). To assess immune … Summary Materials and Methods Results and Discussion • Vancomycin resistant enterococcus (VRE) is a prevalent …
Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus
… Characterization of Phage Resistance Mutations in Vancomycin Resistance Enterococcus G. Allen, J. Berkson, A. … multidrug resistant strains of this genus, most commonly Vancomycin resistant Enterococcus (VRE), prove difficult to … … Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus …
FDA Rationale for Recognition Decision: Daptomycin
… (STIC) for daptomycin for Enterococcus faecalis (including vancomycin-susceptible and vancomycin-resistant isolates) based on a dosing regimen of 4 … BPs should be revised only for E. faecalis (including vancomycin-susceptible and vancomycin-resistant isolates). …
Drug Trials Snapshots: BAXDELA
… to the standard antibacterial combination therapy of vancomycin and aztreonam in stopping the spread of ABSSSI. … with ABSSSI in Trial 1 and Trial 2 Trial BAXDELA IV Vancomycin+Aztreonam IV Treatment Difference** (2-sided 95% … (78.2%) 266 (80.9%) -2.6 (-8.8, 3.6) BAXDELA IV and oral Vancomycin+Aztreonam IV Treatment Difference** (2-sided 95% …
Kidon Sung
… Feb 11, 4(1): e01396-15. Genomic Sequence of a Clinical Vancomycin-Resistant Reference Strain, Enterococcus faecalis … Diversity of Tn1546-Like Elements in Clinical Isolates of Vancomycin-Resistant Enteroccoci . Sung K., Khan S. and Nawaz … Agents. 2008 Jun, 31(6):549-554. Heteroresistance to Vancomycin and Novel Point Mutations in Tn1546 of …
Coronavirus (COVID-19) Update: November 23, 2021
… the FDA approved an abbreviated new drug application for vancomycin hydrochloride for injection , indicated to treat … or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. The side effects of vancomycin hydrochloride for injection include diarrhea, …
Edge Pharma, LLC Issues Voluntary Nationwide Recall of All Drug Products Due to Lack of Sterility Assurance
… (PF) 5% 05446-1680-01 TRYPAN BLUE (PF) 0.03% 05446-1200-01 VANCOMYCIN HCL (PF) 10 MG/ML 05446-0736-01 VANCOMYCIN HCL (PF) 1250 MG/250ML 05446-1456-01 VANCOMYCIN HCL (PF) 1500 MG/512ML 05446-1458-01 VANCOMYCIN …
Saeed Khan
… Diversity of Tn1546-Like Elements in Clinical Isolates of Vancomycin-Resistant Enterococci . Sung K., Khan S. and Nawaz … Agents. 2008 Jun, 31(6):549-54. Heteroresistance to Vancomycin and Novel Point Mutations in Tn 1546 of … from Poultry and Dairy Farms: Detection of Virulence and Vancomycin Resistance Gene Markers by PCR . Khan S., Nawaz …
Daptomycin Injection Products
… mm) Pathogen S I R S I R Enterococcus faecalis (including vancomycin-resistant isolates)* ≤2 4 ≥8 - - - Staphylococcus …
Withdrawn | Infectious Disease Accelerated Approvals
… Synercid (dalfopristin/quinupristin) For the treatment of vancomycin-resistant enterococcus faecium (VREF) 9/21/1999 …
Drug Trials Snapshot: DALVANCE (dalbavancin)
… they were treated with DALVANCE or the comparison drug (Vancomycin/linezolid). Age: The frequency of side … given DALVANCE and 653 others received a combination of Vancomycin and linezolid, which has been the standard therapy … were taking DALVANCE and which patients were taking Vancomycin/linezolid, until after the drug trial was …
July - September 2019 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
… FDA is evaluating the need for regulatory action. Firvanq (vancomycin hydrochloride) Vancocin (vancomycin hydrochloride) Generic products containing vancomycin Serious cutaneous adverse reactions, including …
Information Pertaining to Additional Safety Protections Regarding Use of Fecal Microbiota for Transplantation – Screening and Testing of Stool Donors for Multi-drug Resistant Organisms
… beta-lactamase (ESBL)-producing Enterobacteriaceae, vancomycin-resistant enterococci (VRE), carbapenem-resistant …
Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg/300ml, Due to Presence White Particulate Matter that has been Identified as Mold
… Uncomplicated skin and skin structure infections (1.2); Vancomycin-resistant Enterococcus faecium infections (1.3). …